XML 95 R81.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
RSAs    
Shares    
Number of nonvested shares outstanding, beginning 684,006 475,619
Nonvested shares granted 324,401 592,000
Nonvested shares vested (394,169) (352,762)
Nonvested shares forfeited (96,669) (30,851)
Number of nonvested shares outstanding, ending 517,569 684,006
Weighted Average Grant Date Fair Value    
Weighted average exercise price outstanding, beginning (in usd per share) $ 3.38 $ 2.98
Weighted average exercise price outstanding, nonvested options granted (in usd per share) 5.56 3.52
Weighted average exercise price outstanding, options vested (in usd per share) 3.30 3.12
Weighted average exercise price outstanding, options forfeited (in usd per share) 3.77 2.85
Weighted average exercise price outstanding, ending (in usd per share) $ 4.74 $ 3.38
Unrecognized stock-based compensation expense $ 1,928  
Weighted average remaining vesting period 1 year 7 months 6 days  
RSUs    
Shares    
Number of nonvested shares outstanding, ending 450,000  
Restricted Shares    
Nonvested restricted stock outstanding, beginning balance (in shares) 986,500 900,000
Nonvested restricted stock granted (in shares) 506,500 166,500
Nonvested restricted stock vested (in shares) (28,834) 0
Nonvested restricted stock forfeited (in shares) (450,000) (80,000)
Nonvested restricted stock outstanding, ending balance (in shares) 1,014,166 986,500
Weighted Average Grant Date Fair Value    
Weighted average exercise price outstanding, beginning (in usd per share) $ 1.58 $ 1.42
Weighted average exercise price outstanding, nonvested options granted (in usd per share) 5.84 3.19
Weighted average exercise price outstanding, options vested (in usd per share) 3.19 0
Weighted average exercise price outstanding, options forfeited (in usd per share) 1.42 3.19
Weighted average exercise price outstanding, ending (in usd per share) $ 3.73 $ 1.58
Unrecognized stock-based compensation expense $ 2,823  
Weighted average remaining vesting period 2 years 3 months 18 days